{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:23:07Z","timestamp":1781270587714,"version":"3.54.1"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070679"],"award-info":[{"award-number":["82070679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022SK2040"],"award-info":[{"award-number":["2022SK2040"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005198","name":"Chinese Foundation for Hepatitis Prevention and Control","doi-asserted-by":"publisher","award":["TQGB20210181"],"award-info":[{"award-number":["TQGB20210181"]}],"id":[{"id":"10.13039\/501100005198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Metabolic-associated fatty liver disease (MAFLD) affects approximately a quarter of the global population. Identification of the key genes and pathways involved in hepatic lipid metabolism is of the utmost importance for the diagnosis, treatment, and prevention of MAFLD. In this study, differentially expressed genes were identified through whole-genome transcriptional analysis of liver tissue from MAFLD patients and healthy controls, and a series of lipid metabolism-related molecules and pathways were obtained through pathway analysis. Subsequently, we focused on Iroquois homeobox protein 3 (<jats:italic>IRX3<\/jats:italic>), one of 13 transcription factors that were screened from the 331 differentially expressed genes. The transcription factor <jats:italic>IRX3<\/jats:italic> was significantly decreased in the liver tissue of patients with MAFLD when compared with healthy controls. Pearson\u2019s correlation analysis showed that the expression levels of <jats:italic>IRX3<\/jats:italic> in liver tissue were negatively correlated with serum total cholesterol, triglycerides, low-density lipoprotein cholesterol, and uric acid levels. The overexpression and interference of IRX3 induced the increased and decreased lipid droplet accumulation <jats:italic>in vitro<\/jats:italic>, respectively. Moreover, interference of <jats:italic>IRX3<\/jats:italic> expression increased mitochondrial fragmentation and reduced the activity of the mitochondrial respiratory chain complex IV. In summary, the study demonstrated that <jats:italic>IRX3<\/jats:italic> regulated hepatic lipid metabolism of MAFLD, and also revealed the effect of <jats:italic>IRX3<\/jats:italic> on mitochondria might be an important mechanism by which <jats:italic>IRX3<\/jats:italic> regulated hepatic lipid metabolism of MAFLD.<\/jats:p>","DOI":"10.3389\/fendo.2022.895593","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T08:12:30Z","timestamp":1658823150000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["IRX3 plays an important role in the pathogenesis of metabolic-associated fatty liver disease by regulating hepatic lipid metabolism"],"prefix":"10.3389","volume":"13","author":[{"given":"Yongqiang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangshun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhou","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiequn","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14478","article-title":"What's in a name? renaming 'Nafld' to 'Mafld'","volume":"40","author":"Fouad","year":"2020","journal-title":"Liver Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of nafld and Nash: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22052350","article-title":"Treatments for nafld: State of art","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-Analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: Pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu Rev Pathology-Mechanisms Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i41.6969","article-title":"Pnpla3 I148m polymorphism and progressive liver disease","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhep.2020.08.027","article-title":"Rs641738c>T near Mboat7 is associated with liver fat, alt and fibrosis in nafld: A meta-analysis","volume":"74","author":"Teo","year":"2021","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e87523","DOI":"10.1371\/journal.pone.0087523","article-title":"Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease","volume":"9","author":"Petta","year":"2014","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"Tm6sf2 Rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P089953","article-title":"Splice variant Rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease","volume":"60","author":"Pirola","year":"2019","journal-title":"J Lipid Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of nafld and Nash: Clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101111","article-title":"Genetic and epigenetic factors determining nafld risk","volume":"50","author":"Jonas","year":"2021","journal-title":"Mol Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0142661","DOI":"10.1371\/journal.pone.0142661","article-title":"Performance of serum micrornas -122, -192 and -21 as biomarkers in patients with non-alcoholic steatohepatitis","volume":"10","author":"Becker","year":"2015","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3289-x","article-title":"Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease","volume":"59","author":"Ahn","year":"2014","journal-title":"Digestive Dis Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96094","article-title":"Loss of mir-141\/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in Nash","volume":"2","author":"Tran","year":"2017","journal-title":"JCI Insight"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0196785","DOI":"10.1371\/journal.pone.0196785","article-title":"Tauroursodeoxycholic acid (Tudca) alleviates endoplasmic reticulum stress of nuclear donor cells under serum starvation","volume":"13","author":"Zhang","year":"2018","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature13138","article-title":"Obesity-associated variants within fto form long-range functional connections with Irx3","volume":"507","author":"Smemo","year":"2014","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.11.048","article-title":"The partial inhibition of hypothalamic Irx3 exacerbates obesity","volume":"39","author":"de Araujo","year":"2019","journal-title":"EBioMedicine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13358","article-title":"Annual report of the European liver transplant registry (Eltr) - 50-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transplant Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmet.2018.05.008","article-title":"Sex differences in lipid and lipoprotein metabolism","volume":"15","author":"Palmisano","year":"2018","journal-title":"Mol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.741710","article-title":"Combined analysis of expression profiles in a mouse model and patients identified Bhmt2 as a new regulator of lipid metabolism in metabolic-associated fatty liver disease","volume":"9","author":"Ma","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"Star: Ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","article-title":"Rsem: Accurate transcript quantification from RNA-seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky955","article-title":"Gencode reference annotation for the human and mouse genomes","volume":"47","author":"Frankish","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001067R","article-title":"Identification of Cyp46a1 as a new regulator of lipid metabolism through crispr-based whole-genome screening","volume":"34","author":"Si","year":"2020","journal-title":"FASEB J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1000612","DOI":"10.1371\/journal.pbio.1000612","article-title":"Mechanism of neuroprotective mitochondrial remodeling by Pka\/Akap1","volume":"9","author":"Merrill","year":"2011","journal-title":"PloS Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1222404110","article-title":"Myc inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells","volume":"110","author":"Zirath","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2011.02.005","article-title":"Transcriptional control of adipose lipid handling by Irf4","volume":"13","author":"Eguchi","year":"2011","journal-title":"Cell Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.050186","article-title":"Transcription factor maff (Maf basic leucine zipper transcription factor f) regulates an atherosclerosis relevant network connecting inflammation and cholesterol metabolism","volume":"143","author":"von Scheidt","year":"2021","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.01.002","article-title":"Hypothalamic Irx3: A new player in the development of obesity","volume":"31","author":"de Ara\u00fajo","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13498","article-title":"The composite alliance of fto locus with obesity-related genetic variants","volume":"48","author":"Chauhdary","year":"2021","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.17051","article-title":"Complex relationship between obesity and the fat mass and obesity locus","volume":"13","author":"Yang","year":"2017","journal-title":"Int J Biol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.634191","article-title":"Irx3 overexpression enhances Ucp1 expression in Vivo","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.7150\/jgen.3741","article-title":"Topics in transcriptional control of lipid metabolism: From transcription factors to gene-promoter polymorphisms","volume":"1","author":"Bergen","year":"2013","journal-title":"Int J Genomics"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.761538","article-title":"Liver fibrosis and mafld: From molecular aspects to novel pharmacological strategies","volume":"8","author":"Qu","year":"2021","journal-title":"Front Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhep.2021.01.047","article-title":"A structurally optimized fxr agonist, Met409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis","volume":"75","author":"Harrison","year":"2021","journal-title":"J Hepatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)00803-x","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (Lean): A multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.91","article-title":"Srebp-regulated lipid metabolism: Convergent physiology - divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.146365","article-title":"Tfeb at a glance","volume":"129","author":"Napolitano","year":"2016","journal-title":"J Cell Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/21623945.2019.1693745","article-title":"Interactions between macro-nutrients' intake, fto and Irx3 gene expression, and fto genotype in obese and overweight Male adolescents","volume":"8","author":"Doaei","year":"2019","journal-title":"Adipocyte"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.239309","article-title":"Influence of fat mass- and obesity-associated genotype, body mass index, and dietary intake on effects of Iroquois-related homeobox 3 gene on body weight","volume":"131","author":"Gholamalizadeh","year":"2018","journal-title":"Chin Med J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.5114\/amsad.2019.87545","article-title":"The possible mechanisms of the effects of Irx3 gene on body weight: An overview","volume":"4","author":"Gholamalizadeh","year":"2019","journal-title":"Arch Med Sci - Atherosclerotic Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12214","article-title":"Irx3 is a genetic modifier for birth weight, adolescent obesity and transaminase metabolism","volume":"13","author":"Liu","year":"2018","journal-title":"Pediatr Obes"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3109\/03014460.2015.1103902","article-title":"Association of fto and Irx3 genetic variants to obesity risk in north India","volume":"43","author":"Srivastava","year":"2016","journal-title":"Ann Hum Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"B49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gendis.2021.01.005","article-title":"Critical roles of fto-mediated mrna M6a demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders","volume":"9","author":"Yang","year":"2022","journal-title":"Genes Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.154014","article-title":"The homeobox factor Irx3 maintains adipogenic identity","volume":"103","author":"Bjune","year":"2020","journal-title":"Metabolism"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-018-0275-y","article-title":"Irx5 regulates adipocyte amyloid precursor protein and mitochondrial respiration in obesity","volume":"43","author":"Bjune","year":"2019","journal-title":"Int J Obes"},{"key":"B52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1387\/ijdb.180355ks","article-title":"Mitochondria and lipid metabolism in mammalian oocytes and early embryos","volume":"63","author":"Bradley","year":"2019","journal-title":"Int J Dev Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.02.011","article-title":"Mitochondria bound to lipid droplets: Where mitochondrial dynamics regulate lipid storage and utilization","volume":"29","author":"Benador","year":"2019","journal-title":"Cell Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107815","article-title":"Cd28 regulates metabolic fitness for long-lived plasma cell survival","volume":"31","author":"Utley","year":"2020","journal-title":"Cell Rep"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1038\/s41467-018-04392-5","article-title":"Mtor coordinates transcriptional programs and mitochondrial metabolism of activated T(Reg) subsets to protect tissue homeostasis","volume":"9","author":"Chapman","year":"2018","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.mito.2020.10.004","article-title":"Complex iv - the regulatory center of mitochondrial oxidative phosphorylation","volume":"58","author":"Kadenbach","year":"2021","journal-title":"Mitochondrion"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.168","article-title":"Loss of bim increases mitochondrial oxygen consumption and lipid oxidation, reduces adiposity and improves insulin sensitivity in mice","volume":"25","author":"Wali","year":"2018","journal-title":"Cell Death Differentiation"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1080\/21623945.2017.1297346","article-title":"Age-dependent obesity and mitochondrial dysfunction","volume":"6","author":"Li","year":"2017","journal-title":"Adipocyte"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.895593\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T08:12:38Z","timestamp":1658823158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.895593\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":59,"alternative-id":["10.3389\/fendo.2022.895593"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.895593","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"article-number":"895593"}}